Important Safety Information

Start your Keveyis Journey

Discussing Primary Periodic Paralysis with your family

Talking about PPP with your family can be hard, but sharing your experience can empower your family. We can help you get the conversation started.

PPP is usually an inherited condition1

Your family members may not know they have PPP. Or, if they’re experiencing symptoms, they may not realize that those symptoms could be caused by PPP.

If you’re worried that someone in your family may have PPP, you can pass along facts and useful information in a sensitive way. As your family facilitator, you can help guide their path by encouraging them to discuss PPP with their doctor.

Get the Family Facilitator guide

GENETIC TESTING

Uncover periodic paralysis in your family

If you think you or your family members may have PPP, a genetic test can help shorten the journey to diagnosis and speed up the path to developing a treatment plan.2

Genetic testing does not capture all the genes associated with PPP. It can only confirm a PPP diagnosis in about 70% of people. The remaining 30% of people may have a negative or inconclusive test, but still have PPP.

Xeris Pharmaceuticals® offers a no-cost Periodic Paralysis genetic test to:
  • People with episodic muscle weakness or temporary paralysis associated with common triggers of PPP
  • First-degree family members of anyone diagnosed with PPP
Get the Genetic Testing Guide
Get the Genetic Testing Guide

References

  1. Fontaine B, Phillips LH 2nd. A newly approved drug for a rare group of diseases: dichlorphenamide for periodic paralysis. Neurology. 2016;86:1366-1367.
  2. Statland JM, Fontaine B, Hanna MG, et al. Review of the diagnosis and treatment of periodic paralysis. Muscle Nerve. 2018;57:522-530.

INDICATION AND IMPORTANT SAFETY INFORMATION — READ MORE

Indication and Important Safety Information

Indication

KEVEYIS (dichlorphenamide) is a prescription drug used to treat primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and other similar diseases.

Important Safety Information

  • Do not take KEVEYIS if you:
    • Have liver or severe lung disease
    • Are allergic to dichlorphenamide or other sulfur drugs
    • Are taking high doses of aspirin
  • Discontinue KEVEYIS at the first appearance of skin rash, swelling, difficulty breathing, or any other unexpected side effect or reaction
  • KEVEYIS can cause your body to lose potassium, can cause acid buildup, and can increase your risk of falls. The risk of falls and acid buildup are greater in elderly patients
  • The most common side effects are feeling of tingling or pricking (“pins and needles”) in your toes, feet, and hands and fingers; trouble with memory or thinking; unpleasant taste in the mouth; and feeling confused
  • Before taking KEVEYIS, tell your doctor about all the medicines you take, medical conditions, and if you are pregnant or plan to become pregnant
  • You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088

For more information, see full Prescribing Information for KEVEYIS.

Xeris

Keveyis®, Xeris Pharmaceuticals®, Xeris CareConnection™, PPP MentorConnect™, and their associated logos are trademarks owned by or licensed to Xeris Pharmaceuticals, Inc.

FOR PATIENTS

OTHER

Copyright © 2024 Xeris Pharmaceuticals, Inc. All rights reserved.
US-KEV-24-00029 7/2024

Find answers

Take the next step

Get customized support for your KEVEYIS journey. Simply fill out the information and a Patient Access Manager will contact you. They will walk you through the entire process, from diagnosis to treatment and beyond.

By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.

Keveyis
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.